JP2017222707A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017222707A5 JP2017222707A5 JP2017153348A JP2017153348A JP2017222707A5 JP 2017222707 A5 JP2017222707 A5 JP 2017222707A5 JP 2017153348 A JP2017153348 A JP 2017153348A JP 2017153348 A JP2017153348 A JP 2017153348A JP 2017222707 A5 JP2017222707 A5 JP 2017222707A5
- Authority
- JP
- Japan
- Prior art keywords
- light
- wavelength
- less
- maximum transmittance
- brimonidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 5
- 238000002834 transmittance Methods 0.000 claims 4
- XYLJNLCSTIOKRM-UHFFFAOYSA-N Alphagan Chemical compound C1=CC2=NC=CN=C2C(Br)=C1NC1=NCCN1 XYLJNLCSTIOKRM-UHFFFAOYSA-N 0.000 claims 3
- 229960003679 brimonidine Drugs 0.000 claims 3
- 229940054534 ophthalmic solution Drugs 0.000 claims 3
- 239000002997 ophthalmic solution Substances 0.000 claims 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- 229930195725 Mannitol Natural products 0.000 claims 2
- HCRKCZRJWPKOAR-JTQLQIEISA-N brinzolamide Chemical compound CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S(N)(=O)=O)S2 HCRKCZRJWPKOAR-JTQLQIEISA-N 0.000 claims 2
- 229960000722 brinzolamide Drugs 0.000 claims 2
- 235000010355 mannitol Nutrition 0.000 claims 2
- 239000000594 mannitol Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 229940127557 pharmaceutical product Drugs 0.000 claims 2
- 230000006641 stabilisation Effects 0.000 claims 2
- 238000011105 stabilization Methods 0.000 claims 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015241390 | 2015-12-10 | ||
| JP2015241390 | 2015-12-10 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017514571A Division JP6192878B1 (ja) | 2015-12-10 | 2016-12-09 | 眼科用医薬製品 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021000497A Division JP7019844B2 (ja) | 2015-12-10 | 2021-01-05 | 眼科用医薬製品 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017222707A JP2017222707A (ja) | 2017-12-21 |
| JP2017222707A5 true JP2017222707A5 (enExample) | 2020-01-23 |
| JP6820812B2 JP6820812B2 (ja) | 2021-01-27 |
Family
ID=59013225
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017514571A Active JP6192878B1 (ja) | 2015-12-10 | 2016-12-09 | 眼科用医薬製品 |
| JP2017153348A Active JP6820812B2 (ja) | 2015-12-10 | 2017-08-08 | 眼科用医薬製品 |
| JP2021000497A Active JP7019844B2 (ja) | 2015-12-10 | 2021-01-05 | 眼科用医薬製品 |
| JP2022014648A Active JP7263579B2 (ja) | 2015-12-10 | 2022-02-02 | 眼科用医薬製品 |
| JP2023064795A Active JP7494351B2 (ja) | 2015-12-10 | 2023-04-12 | 眼科用医薬製品 |
| JP2024083625A Pending JP2024098100A (ja) | 2015-12-10 | 2024-05-22 | 眼科用医薬製品 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017514571A Active JP6192878B1 (ja) | 2015-12-10 | 2016-12-09 | 眼科用医薬製品 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021000497A Active JP7019844B2 (ja) | 2015-12-10 | 2021-01-05 | 眼科用医薬製品 |
| JP2022014648A Active JP7263579B2 (ja) | 2015-12-10 | 2022-02-02 | 眼科用医薬製品 |
| JP2023064795A Active JP7494351B2 (ja) | 2015-12-10 | 2023-04-12 | 眼科用医薬製品 |
| JP2024083625A Pending JP2024098100A (ja) | 2015-12-10 | 2024-05-22 | 眼科用医薬製品 |
Country Status (2)
| Country | Link |
|---|---|
| JP (6) | JP6192878B1 (enExample) |
| WO (1) | WO2017099207A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1009419B (el) * | 2017-11-07 | 2018-12-14 | Φαρματεν Αβεε | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου |
| JP2019178083A (ja) * | 2018-03-30 | 2019-10-17 | 参天製薬株式会社 | 点眼用水溶液 |
| WO2020071297A1 (ja) * | 2018-10-01 | 2020-04-09 | 千寿製薬株式会社 | 水性液剤 |
| JP6798001B1 (ja) * | 2019-12-27 | 2020-12-09 | 千寿製薬株式会社 | 医薬製品 |
| JP7728656B2 (ja) * | 2020-04-27 | 2025-08-25 | 千寿製薬株式会社 | ブリモニジンを含有する液体製剤 |
| WO2021220194A1 (en) * | 2020-04-29 | 2021-11-04 | Sentiss Pharma Private Limited | Ophthalmic compositions comprising a combination of brinzolamide and brimonidine |
| JP2022063252A (ja) * | 2020-10-09 | 2022-04-21 | 千寿製薬株式会社 | ブリモニジンの液体製剤 |
| JP2022187495A (ja) * | 2021-06-07 | 2022-12-19 | 千寿製薬株式会社 | ブリモニジンの液体製剤 |
| JP2024097772A (ja) * | 2023-01-06 | 2024-07-19 | 千寿製薬株式会社 | 医薬製品 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5153192A (en) * | 1990-04-09 | 1992-10-06 | Alcon Laboratories, Inc. | Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
| WO2004073708A1 (en) * | 1998-12-17 | 2004-09-02 | Dean Thomas R | Brinzolamide and brimonidine for treating ocular conditions |
| JP2014055028A (ja) * | 2012-09-14 | 2014-03-27 | Senju Pharmaceut Co Ltd | 光による分解から薬物を保護するためのプラスチック容器 |
| JP6339364B2 (ja) * | 2013-12-27 | 2018-06-06 | カズマパートナーズ株式会社 | 無定形ブリモニジン酒石酸塩及びその製造方法 |
-
2016
- 2016-12-09 JP JP2017514571A patent/JP6192878B1/ja active Active
- 2016-12-09 WO PCT/JP2016/086662 patent/WO2017099207A1/ja not_active Ceased
-
2017
- 2017-08-08 JP JP2017153348A patent/JP6820812B2/ja active Active
-
2021
- 2021-01-05 JP JP2021000497A patent/JP7019844B2/ja active Active
-
2022
- 2022-02-02 JP JP2022014648A patent/JP7263579B2/ja active Active
-
2023
- 2023-04-12 JP JP2023064795A patent/JP7494351B2/ja active Active
-
2024
- 2024-05-22 JP JP2024083625A patent/JP2024098100A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017222707A5 (enExample) | ||
| CY1122122T1 (el) | Υδατικο οφθαλμικο διαλυμα και μεθοδος για τη θεραπευτικη αγωγη συνδρομου ξηρου οφθαλμου | |
| ES2663817T3 (es) | Proceso para producir una disolución inyectable estable de noradrenalina a baja concentración | |
| EA201491771A1 (ru) | Офтальмологический раствор, содержащий диквафасол | |
| EA201592198A1 (ru) | Производные сульфамоилтиофенамида и их применение в качестве медикаментов для лечения гепатита b | |
| BR112017010141A2 (pt) | Forma cristalina de hidrogenossulfato de (s)-n-(5- ((r)-2-(2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5- a]pirimidin-3-il)-3-hidroxipirrolidina-1-carboxamida | |
| EP2968973A4 (en) | FOR THE EYE IMPROPER LASER RADIATION IN EYE SURGERY | |
| CO7141410A2 (es) | Compuesto heterocíclico nitrogenado | |
| BR112017015852A2 (pt) | forma de cristal, sal hemicálcico, sal hemicálcico di-hidratado, sal monossódico hidratado, sal bissódico monoidratado, sal monossódico anidro e método para preparar o composto 1 | |
| EA201791467A1 (ru) | Водный офтальмологический раствор | |
| PE20180143A1 (es) | Envase para autenticacion fotosensible multi-instancia | |
| MX2016009049A (es) | Composicion farmaceutica que contiene compuesto de acido piridilaminoacetico. | |
| MX386702B (es) | Tratamiento con halogeno de ataque cardiaco y lesion isquemica. | |
| CL2017000382A1 (es) | Compuestos bicíclicos sustituidos | |
| JP2015030689A5 (enExample) | ||
| JP2016535044A5 (enExample) | ||
| GT201300089A (es) | Nuevas formas cristalinas de la sal sodica del acido (4-(4-(5-(6-trifluoro-metil-piridin-3-il-amino)-piridin-2-il)-fenil)-ciclohexil)-acetico | |
| JP2011063624A5 (enExample) | ||
| CY1119520T1 (el) | Αλατα 1-(3-μεθυλ-2-οξο-2,3-διυδρο-1,3-βενζοξαζολ-6-υλ)-2,4-διοξο-3-[(1r)-4-(τριφθορομεθυλ)-2,3-διυδρο-1η-ινδενο-1-υλ]-1,2,3,4-τετραϋδροπυριμιδιν-5-καρβοξυλικου οξεος | |
| EP3569242A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING SULGLYCOTIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF SUCH FOR THE PURPOSE OF PREVENTION OR TREATMENT OF DRY EYE | |
| JP2017531030A5 (enExample) | ||
| RU2017114136A (ru) | Композиции | |
| CL2017002900A1 (es) | Autenticación de envasado | |
| RU2013133548A (ru) | Кровоостанавливающий препарат | |
| LT3217998T (lt) | Kompozicijos, turinčios apoekvorino, skirtos naudoti neuroninių ląstelių žūties nuo išemijos gydymo būde, įvedant jas peroraliai |